Press Releases July 24, 2026 04:05 PM

LifeMD to Report Second Quarter 2026 Financial Results on August 5

LifeMD announces Q2 2026 earnings release and conference call on August 5

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
LFMD

LifeMD, a leading virtual primary care provider, will release its financial results for Q2 2026 after market close on August 5, 2026, followed by a conference call for investors and analysts.

LifeMD to Report Second Quarter 2026 Financial Results on August 5
LFMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LifeMD provides virtual primary care services including telemedicine, lab, and pharmacy services.
  • The company serves over 200 conditions with specialized treatments such as men’s and women’s health, weight management, and hormone therapy.
  • LifeMD operates through a proprietary digital care platform and a fully integrated medical group and pharmacy across all 50 states.

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date:Wednesday, August 5thTime:4:30 p.m. Eastern timeToll-Free Dial-In:(800) 715-9871International Dial-In:+1 (646) 307-1963Conference ID:3616168 (“LifeMD, Inc. Second Quarter 2026 Results”)Live & Archived Webcast:Link  

Participants may also use the “Dial-Me In” option by visiting this link and entering their details.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care services. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Investor Contact
[email protected]

Media Contact
[email protected]


Risks

  • Financial results might not meet market expectations, affecting stock price.
  • Regulatory changes in telehealth and healthcare services could impact operations.
  • Competitive pressures in the digital healthcare and telemedicine sectors may challenge growth.

More from Press Releases

SiriusPoint Announces Date for Second Quarter 2026 Earnings Release Jul 24, 2026 Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders Jul 24, 2026 NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026 Jul 24, 2026 Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency Jul 24, 2026 AMREP Reports Fiscal 2026 Results Jul 24, 2026